Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
Université Claude Bernard Lyon 1 · CHU Dijon Bourgogne
Abstract
PURPOSE: In 1992, preoperative radiotherapy was considered in France as the standard treatment for T3-4 rectal cancers. The present randomized trial compares preoperative radiotherapy with chemoradiotherapy. PATIENTS AND METHODS: Patients were eligible if they presented a resectable T3-4, Nx, M0 rectal adenocarcinoma accessible to digital rectal examination. Preoperative radiotherapy with 45 Gy in 25 fractions during 5 weeks was delivered. Concurrent chemotherapy with fluorouracil 350 mg/m2/d during 5 days, together with leucovorin, was administered during the first and fifth week in the experimental arm. Surgery was planned 3 to 10 weeks after the end of radiotherapy. All patients should receive adjuvant…
Citation impact
- FWCI
- 32.59
- Percentile
- 100%
- References
- 29
Authors
15- JGJean‐Pierre GérardCorresponding
Université Claude Bernard Lyon 1, CHU Dijon Bourgogne
- TCThierry Conroy
Université Claude Bernard Lyon 1, CHU Dijon Bourgogne
- FBFranck Bonnetain
Université Claude Bernard Lyon 1, CHU Dijon Bourgogne
- OBOlivier Bouché
Université Claude Bernard Lyon 1, CHU Dijon Bourgogne
- OCO. Chapet
Université Claude Bernard Lyon 1, CHU Dijon Bourgogne
Topics & keywords
- Medicine
- Chemoradiotherapy
- Radiation therapy
- Fluorouracil
- Rectum
- Regimen
- Surgery
- Adenocarcinoma
- Good health and well-being